Citius Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
1292.681.350.95
Price/Sales ratio
2.250.940.560.42
Earnings per Share (EPS)
$0.01$0.48$0.95$1.35

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
N/A-466.18-103.13-41.61-35.73-24.51-57.61-238.32-131.35-76.82-0.00-35.73
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
N/A-2.13K51.0219.6816.0715.6630.2441.6942.9727.520.0015.66
Price/Cash Flow ratio
N/A-567.19-144.99-54.21-39.58-30.70-60.14-227.27-155.81-86.03-0.00-39.58
Price/Free Cash Flow ratio
N/A-567.19-144.99-54.19-39.58-30.70-60.13-85.77-155.81-86.03-0.00-39.58
Price/Earnings Growth ratio
N/AN/A-1.532.380.930.711.384.46-13.79N/AN/A0.71
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
9.36%-0.15%-0.10%-8.19%-10.24%-0.10%-0.71%-0.30%-1.74%-1.80%-0.52%-10.24%
Return on Assets
-81.68%-391.38%-37.79%-42.53%-40.37%-53.74%-40.37%-16.23%-29.50%-31.40%-25.07%-40.37%
Return On Equity
171.46%456.89%-49.47%-47.31%-44.98%-63.90%-52.49%-17.49%-32.71%-35.82%-26.01%-44.98%
Return on Capital Employed
155.40%508.47%-44.42%-45.50%-49.48%-63.98%-44.63%-16.99%-30.43%-37.54%-22.44%-49.48%
Liquidity Ratios
Current Ratio
0.670.530.171.383.151.723.41N/AN/AN/A9.323.15
Quick Ratio
0.670.530.171.383.151.723.4118.289.835.948.133.15
Cash ratio
0.670.490.051.292.881.713.3817.599.204.588.132.88
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/A247.09K83.54K327.61K1.10M4.44K2.82K2.36K5.49KN/A1.10M
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.38N/A0.030.000.000.000.010.000.00N/A0.090.00
Debt Equity Ratio
-0.80N/A0.040.000.000.000.010.000.00N/A0.100.00
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/A0.00N/AN/AN/A0.00N/A
Total Debt to Capitalization
-4.22N/A0.030.000.000.000.010.000.00N/A0.000.00
Interest Coverage Ratio
N/A-430.65-828.25-11.73-870.63-948.63-1.13KN/AN/AN/A-110.64-870.63
Cash Flow to Debt Ratio
-1.17N/A-8.76-46.08-65.43-71.90-34.09-136.82-143.97N/A-45.23-65.43
Company Equity Multiplier
-2.09-1.161.301.111.111.181.301.071.101.141.111.18
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1111.00111.002.641111
Cash Flow Coverage Ratio
-1.17N/A-8.76-46.08-65.43-71.90-34.09-136.82-143.97N/A-45.23-65.43
Short Term Coverage Ratio
-1.17N/A-8.76-46.08-65.43-71.90-51.00-136.82-143.97N/A-141.13-71.90
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A